Many labs have stopped performing the Schilling test, due to lack of production of the cobalt radioisotopes and labeled-B test substances. Also, injection replacement of B has become relatively inexpensive, and can be self-administered by patients, as well as megadose oral B. Since these are the same treatments which would be administered for most causes of B malabsorption even if the exact cause were identified, the diagnostic test may be omitted without damage to the patient (so long as follow-up treatment and occasional serum B testing is not allowed to lapse).